What did @rejuvimemedical actually say?
The video runs through four myths about testosterone replacement therapy and hormone replacement therapy. The creator claims HRT and TRT aren't just for older adults, that side effects are manageable under medical supervision, that these therapies go beyond libido, and that they don't cause weight gain. They wrap up by pointing viewers to their clinic's website.
The framing is myth-busting, which is a format that tends to flatten nuance. Each claim gets about ten seconds of airtime. That's enough to plant a flag, not enough to explain the caveats that matter for anyone actually considering these therapies. The creator doesn't specify which hormones, which patient populations, or which delivery methods they're talking about, and that vagueness does real work here.
Does the science back this up?
Partially, yes. The core arguments aren't fabricated, but they're presented with more confidence than the evidence warrants, especially on weight regulation.
On age: Hypogonadism isn't exclusively an older adult condition. Secondary hypogonadism affects younger men, and studies confirm testosterone deficiency can occur across age groups (Bhasin et al., 2018, Journal of Clinical Endocrinology and Metabolism). For women, HRT use in perimenopause and early menopause is well-supported by the Menopause Society's updated 2022 position statement. So the age myth is genuinely worth correcting.
On safety under supervision: This is mostly accurate, but supervision quality varies enormously. A 2019 review in the New England Journal of Medicine noted that while serious cardiovascular adverse events from TRT in hypogonadal men appear low when patients are properly screened, polycythemia and erythrocytosis remain real risks requiring lab monitoring. Saying side effects are simply "manageable" glosses over that.
On weight regulation: This is where the video oversells. Some studies show testosterone therapy in genuinely hypogonadal men associates with modest reductions in fat mass (Saad et al., 2016, Obesity Reviews), but the mechanism the creator describes, "increasing your metabolism," is an oversimplification that edges into marketing language.
What did they get wrong (or right)?
They got the age myth right. They got the libido-only myth right. They got meaningfully wrong is the weight claim and the framing around side effects.
Saying TRT "can help regulate your weight by increasing your metabolism" treats a modest, population-level signal as a reliable outcome for individual patients. That's not how this works. Testosterone therapy's effects on body composition are dose-dependent, vary by baseline testosterone level, and are not a substitute for addressing diet or activity. The TRAVERSE trial (Lincoff et al., 2023, New England Journal of Medicine) showed no excess cardiovascular risk in men with hypogonadism treated with testosterone, which is good news, but it wasn't a weight loss trial.
The side effect claim deserves more than "manageable." Erythrocytosis, changes in fertility, testicular atrophy, acne, and mood shifts are real and not trivial. None of this makes TRT dangerous in appropriate patients. It does make it more complicated than a ten-second reassurance suggests.
What should you actually know?
TRT and HRT are legitimate, evidence-supported treatments for diagnosed hormonal deficiencies. They are not wellness supplements, and the difference matters legally and clinically.
Before starting either therapy, a physician should confirm diagnosis through symptom review and blood work, not just symptoms alone. The Endocrine Society guidelines recommend at least two morning testosterone measurements on separate days before diagnosing male hypogonadism. Age alone is not a reason to avoid these therapies, but age-related symptom overlap with other conditions means workup matters.
- Testosterone therapy requires ongoing lab monitoring, including hematocrit, PSA in older men, and lipid panels.
- HRT in women has different risk profiles depending on whether it's estrogen-alone or combined, and whether the patient has a uterus.
- The 2022 Menopause Society position statement supports HRT for symptom management in healthy women under 60 who are within ten years of menopause onset.
- Anyone considering these therapies should work with a provider who orders baseline labs and follows up, not one who skips the diagnostic step.